OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 641 - 650 of 796 studies

Musculoskeletal

First-in-human study to assess the safety and feasibility of intra-articular administration of allogeneic engineered gingival fibroblasts (aeGF) in participants with knee osteoarthritis (GF-OA-001)

Cancer and neoplasms

A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants with Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

A feasibility study of Remote Patient-Reported Outcome measures in Mitochondrial disease and Spinocerebellar ataxias (R-PROMS)

Cancer and neoplasms

A Phase 1, open-label, multicenter, dose-escalation and cohort expansion study of OKN4395, a dual antagonist of EP2 and EP4 prostanoid receptors, as monotherapy and in combination with pembrolizumab, in patients with advanced solid tumors (INVOKE Trial (OKN-4395-121))

Cancer and neoplasms

A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084 with FOLFOX plus Cetuximab versus FOLFOX with or without Bevacizumab as First-line Treatment of Participants with KRAS G12C Mutant, Metastatic Colorectal Cancer

Cancer and neoplasms

A Phase II/III, multisite, randomized master protocol for a global trial of BNT327 in combination with chemotherapy and other investigational agents in first-line non-small cell lung cancer

Establishment of a research register for patients and families of inherited cardiac condition/cardiomyopathy services (GenetICC)

Synergy Digital Health Assessing the relationship between everyday physical activity and exercise capacity in patients with a Fontan circulation

Cancer and neoplasms

Safety, Tolerability, Pharmacokinetics, and Antitumour Activity of WEF-001 in participants with KRAS-Mutant Advanced Solid Tumours (WEF-001-01)

A Multi-Country Observational Chart Review Study to Characterize Treatment Patterns and Clinical Outcomes among Patients with Resectable Gastric or Gastroesophageal Junction Cancer (GALERAS)